Found: 11
Select item for more details and to access through your institution.
Relationships between Proliferative Activity and Oncogene Expression in Human Breast Cancer<sup> a</sup>.
- Published in:
- Annals of the New York Academy of Sciences, 1996, v. 784, n. 1, p. 555, doi. 10.1111/j.1749-6632.1996.tb16280.x
- By:
- Publication type:
- Article
Composite risk and benefit from adjuvant dose-dense chemotherapy in hormone receptor-positive breast cancer.
- Published in:
- NPJ Breast Cancer, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41523-021-00286-w
- By:
- Publication type:
- Article
5-Fluorouracil, epirubicin and cyclophosphamide versus epirubicin and paclitaxel in node-positive early breast cancer: a phase-III randomized GONO-MIG5 trial.
- Published in:
- Breast Cancer Research & Treatment, 2016, v. 155, n. 1, p. 117, doi. 10.1007/s10549-015-3655-1
- By:
- Publication type:
- Article
Androgen receptor expression is a significant prognostic factor in estrogen receptor positive breast cancers.
- Published in:
- Breast Cancer Research & Treatment, 2011, v. 124, n. 3, p. 607, doi. 10.1007/s10549-010-0761-y
- By:
- Publication type:
- Article
High miR-21 expression in breast cancer associated with poor disease-free survival in early stage disease and high TGF-β1.
- Published in:
- Breast Cancer Research & Treatment, 2009, v. 117, n. 1, p. 131, doi. 10.1007/s10549-008-0219-7
- By:
- Publication type:
- Article
Prognostic significance of changes in CA 15-3 serum levels during chemotherapy in metastatic breast cancer patients.
- Published in:
- Breast Cancer Research & Treatment, 2006, v. 98, n. 3, p. 241, doi. 10.1007/s10549-005-9155-y
- By:
- Publication type:
- Article
Capecitabine in combination with docetaxel and epirubicin in patients with previously untreated, advanced breast carcinoma.
- Published in:
- Cancer (0008543X), 2003, v. 97, n. 5, p. 1174, doi. 10.1002/cncr.11203
- By:
- Publication type:
- Article
Dose‐dense adjuvant chemotherapy in HER2‐positive early breast cancer patients before and after the introduction of trastuzumab: Exploratory analysis of the GIM2 trial.
- Published in:
- International Journal of Cancer, 2020, v. 147, n. 1, p. 160, doi. 10.1002/ijc.32789
- By:
- Publication type:
- Article
A Phase II Study of Three-Weekly Docetaxel and Weekly Trastuzumab in HER2-Overexpressing Advanced Breast Cancer.
- Published in:
- Oncology, 2004, v. 66, n. 1, p. 38, doi. 10.1159/000076333
- By:
- Publication type:
- Article
Randomised phase 3 open-label trial of first-line treatment with gemcitabine in association with docetaxel or paclitaxel in women with metastatic breast cancer: a comparison of different schedules and treatments.
- Published in:
- BMC Cancer, 2013, v. 13, n. 1, p. 1, doi. 10.1186/1471-2407-13-164
- By:
- Publication type:
- Article
Randomised phase 3 open-label trial of first-line treatment with gemcitabine in association with docetaxel or paclitaxel in women with metastatic breast cancer: a comparison of different schedules and treatments.
- Published in:
- 2013
- By:
- Publication type:
- journal article